FR2399430A1 - Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif - Google Patents

Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif

Info

Publication number
FR2399430A1
FR2399430A1 FR7822875A FR7822875A FR2399430A1 FR 2399430 A1 FR2399430 A1 FR 2399430A1 FR 7822875 A FR7822875 A FR 7822875A FR 7822875 A FR7822875 A FR 7822875A FR 2399430 A1 FR2399430 A1 FR 2399430A1
Authority
FR
France
Prior art keywords
tetrahydrofuroyl
quinazolinyl
dimethoxy
amino
antihypertensify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7822875A
Other languages
English (en)
Other versions
FR2399430B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26760383&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2399430(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2399430A1 publication Critical patent/FR2399430A1/fr
Application granted granted Critical
Publication of FR2399430B1 publication Critical patent/FR2399430B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne un nouveau composé, utile notamment comme agent antihypertensif, le chlorhydrate dihydraté de 1-(4-amino-6,7-diméthoxy-2-quinazolinyl)- 4 - (2-tétrahydrofuroyl)pipérazine. Ce composé répond à la formule :
FR7822875A 1977-08-04 1978-08-02 Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif Granted FR2399430A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82167577A 1977-08-04 1977-08-04
US06/078,317 US4251532A (en) 1977-08-04 1979-09-24 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Publications (2)

Publication Number Publication Date
FR2399430A1 true FR2399430A1 (fr) 1979-03-02
FR2399430B1 FR2399430B1 (fr) 1982-08-13

Family

ID=26760383

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7822875A Granted FR2399430A1 (fr) 1977-08-04 1978-08-02 Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif

Country Status (8)

Country Link
US (1) US4251532A (fr)
JP (1) JPS5427588A (fr)
AU (1) AU517636B2 (fr)
CA (1) CA1081229A (fr)
CH (1) CH635096A5 (fr)
DE (1) DE2831112A1 (fr)
FR (1) FR2399430A1 (fr)
GB (1) GB1591490A (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE56007T1 (de) * 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
CA2077252C (fr) * 1992-08-31 2001-04-10 Khashayar Karimian Methodes de fabrication d'urees et de guanidines et composes intermediaires servant a ces syntheses
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5412095A (en) * 1993-04-29 1995-05-02 Abbott Laboratories Terazosin monohydrochloride and processes and intermediate for its production
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
US5504207A (en) * 1994-10-18 1996-04-02 Abbott Laboratories Process and intermediate for the preparation of terazosin hydrochloride dihydrate
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
IT1286790B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridrato anidro
IT1286789B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridato anidro
EP0849265A1 (fr) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Nouvelle forme polymorphique de mésylate de doxazosin (forme II)
EP0849264A1 (fr) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Nouvelle forme polymorphique de mésylate de doxazosin (forme I)
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070161791A1 (en) * 2006-01-09 2007-07-12 Narsimha Reddy Penthala Process for the preparation of terazosin hydrocloride dihydrate
CN103739596A (zh) * 2013-12-10 2014-04-23 刘磊 用于心脑血管疾病的喹唑啉衍生物
US11224572B1 (en) 2020-08-17 2022-01-18 Novitium Pharma LLC Stable oral liquid composition of terazosin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327787A1 (fr) * 1975-10-14 1977-05-13 Abbott Lab Nouveaux agents antihypertenseurs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327787A1 (fr) * 1975-10-14 1977-05-13 Abbott Lab Nouveaux agents antihypertenseurs

Also Published As

Publication number Publication date
AU3781878A (en) 1980-01-10
FR2399430B1 (fr) 1982-08-13
GB1591490A (en) 1981-06-24
JPS5427588A (en) 1979-03-01
AU517636B2 (en) 1981-08-13
CA1081229A (fr) 1980-07-08
CH635096A5 (fr) 1983-03-15
JPH0231078B2 (fr) 1990-07-11
DE2831112A1 (de) 1979-02-15
US4251532A (en) 1981-02-17

Similar Documents

Publication Publication Date Title
FR2399430A1 (fr) Chlorhydrate dihydrate de 1-(4-amino-6, 7-dimethoxy-2-quinazolinyl)-4- (2-tetrahydrofuroyl)piperazine, et son utilisation comme agents antihypertensif
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
FR2372624A1 (fr) Mercaptoacylamino-acides et leur utilisation pour soulager l'hypertension due a l'angiotensine
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
RS49673B (sr) Inhibitori sintaze azot-monoksida
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
TR200102800T2 (tr) Yeni bileşikler.
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
FR2392007A1 (fr) 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy-piperidines, leurs derives, leur preparation et leur utilisation comme antidiarrheiques et analgesiques
FR2382434A1 (fr) N'-(4-phenethyloxy substitue)phenyl) - n - methyl - n - methoxyurees et leur utilisation comme herbicides
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
DE60112960D1 (de) Kondensierte pyridoindolderivate
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ES2007759A6 (es) Una composicion fungicida y procedimiento para su preparacion.
DE59108770D1 (de) Fluorverbindungen als Aromatase-Inhibitoren
FR2405942A1 (fr) Procede d'obtention du 3-oxa-tricyclo (6.2.1.02,7) undecane-4-one et son utilisation a titre d'agent parfumant
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE